药物洗脱支架的成本效益分析
被引量:1
Cost-efficient of the drug eluting stents
出处
《武警医学院学报》
CAS
2007年第4期469-471,共3页
Acta Academiae Medicinae CPAPF
作者简介
杨涛(1969-),男,籍贯天津,本科,副主任医师,主要从事心血管内科专业。
参考文献18
-
1Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stentin patients with coronary artery disease [ J ]. N Engl J Med, 2004, 350 (6): 221-231.
-
2Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J]. N Engl J Med, 2003, 349 (11): 1315-1323.
-
3Serruys PW, Unger F, Sousa JE, et al. The Arterial Revascularization Therapies Study Group. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease [J]. N Engl J Med, 2001, 344 (10): 1117-1124.
-
4Rihal CS, Raco DL, Gersh BJ, et al. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations [ J ]. Circulation, 2003, 108 (12): 2439 - 2445.
-
5Weaver WD, Reisman MA, Griffin JJ, et al. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-I): a randomised trial [J]. Lancet, 2000, 355 (7): 2199-2203.
-
6Rinfret S, Grines CL, Cosgrove RS, et al. Quality of life after balloon angioplasty or stenting for acute myocardial infarction: oneyear results from the Stent-PAMI trial [J]. J Am Coll Cardiol, 2001, 38 (6): 1614-1621.
-
7Cohen DJ, Cosgrove R, Berezin R, et al. Cost-effectiveness of eptifibatide in patients undergoing planned coronary stenting: results from the ESPRIT trial [J]. Circulation, 2001, 104 (2): 386 - 387.
-
8Cohen DJ, Cosgrove RS, Berezin R, et al. Cost-effectiveness of gamma radiation for treatment of in-stent restenosis: results from the Gamma-1 trial [J]. Circulation, 2002, 106 (7): 691- 697.
-
9Cohen DJ, Taira DA, Berezin R, et al. Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) trial. Circulation, 2001, 104 (11): 3039-3045.
-
10Greenberg D, Bakhai A, Neumann PJ, et al. Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study [J]. Health Policy, 2004, 70 (2): 207- 216.
同被引文献28
-
1吕树铮,汪国忠.2011美国经皮冠状动脉介入治疗指南解读[J].中国医学前沿杂志(电子版),2012,4(6):41-48. 被引量:13
-
2李锐洁,李静,陈玉成,曾智.药物洗脱支架治疗冠状动脉疾病的Meta分析[J].中国循证医学杂志,2005,5(7):519-535. 被引量:10
-
3吴大庆.药物洗脱支架在冠状动脉粥样硬化性心脏病治疗中的应用[J].中国组织工程研究与临床康复,2007,11(21):4206-4209. 被引量:4
-
4韩晓峰,刘作军,王健.ST段抬高性心肌梗死应用药物洗脱支架直接PCI支架血栓发生率[J].中国煤炭工业医学杂志,2007,10(10):1221-1221. 被引量:1
-
5Muller-Riemenschneider F, Reinhold T, Willich S N. Sec- ond-generation DES : New, but also cost-effective? [ J ]. Herz, 2011, 36(3): 254-261.
-
6Bischof M, Briel M, Bucher H C, et al. Cost-effectiveness of drug-eluting stents in a US Medicare setting: a cost-utility analysis with 3-year clinical follow-up data [ J ]. Value Health, 2009, 12(5) : 649-656.
-
7Neyt M, Van Brabandt H, Devriese S, et al. Cost-effec- tiveness analyses of drug eluting stents versus bare metal stems: a systematic review of the literature [ J ]. Health Policy, 2009, 91(2): 107-120.
-
8Hill R A, Boland A, Dickson R, et al. Drug-eluting stents: a systematic review and economic evaluation [ J ]. Health Technol Assess, 2007, 11 (46) : 221.
-
9Kuukasjarvi P, Rasanen P, Malmivaara A, et al. Econom- ic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis [ J ]. Int J Technol Assess Health Care, 2007, 23 (4) : 473-479.
-
10Ligthart S, Vlemmix F, Dendukuri N, et al. The cost-ef- fectiveness of drug-eluting stents : a systematic review [ J ]. CMAJ, 2007, 176(2): 199-205.
二级引证文献5
-
1刘晨.上海市普陀区社区医院卫生服务政策执行情况研究[J].医学与社会,2015,28(7):42-44. 被引量:1
-
2祁方家,冯莎,吴伟栋,应晓华.药物洗脱支架火鹰(Firehawk)与XIENCE V治疗单支单处冠状动脉病变的卫生经济学评价[J].中国卫生资源,2015,18(4):283-286. 被引量:10
-
3包家立,朱朝阳.医疗器械微观卫生技术评估框架[J].中国医疗设备,2020,35(7):6-10. 被引量:6
-
4魏龙天,秦贞良.卫生技术评估在医院大型医疗设备采购中的应用[J].医疗装备,2023,36(5):32-35. 被引量:5
-
5明坚,陈英耀,魏艳,许艳.美国心血管医疗服务过度使用分析及启示[J].中国卫生质量管理,2016,23(3):122-125. 被引量:1
-
1林云鹏.DES置入术后CK-MB水平升高提示远期预后不良[J].中国心血管病研究,2008,6(9):659-659.
-
2曹晶茗,肖践明,刘中梅,刘蓉,蔡红雁,张云红,许峰,郭涛,韩明华.应用冠脉血管内超声评价药物涂层支架置放后再狭窄及血管内膜增生[J].介入放射学杂志,2007,16(10):657-660. 被引量:4
-
3汪革平.电视腹腔镜治疗不孕症46例分析[J].华夏医学,2009,22(2):354-355.
-
4冯秀山,王慧兰,陈佩芳.介入、外科手术与药物保守治疗子宫疤痕妊娠的成本效益分析[J].福建医药杂志,2017,39(1):30-32. 被引量:4
-
5马鸿雁,刘同库,孙凤,郑士玉,张婧娴,邵润卓.金属裸支架植入治疗冠状动脉不同病变的远期疗效比较[J].北华大学学报(自然科学版),2015,16(2):210-213. 被引量:1
-
6刘志东.雷帕霉素和紫杉醇药物洗脱支架在冠状动脉长病变中的临床应用分析[J].四川医学,2009,30(12):1904-1905. 被引量:1
-
7曾菲,左绪磊.异位妊娠三种治疗方法疗效与效益分析[J].中国实用妇科与产科杂志,2002,18(4):239-240. 被引量:32
-
8张成举.国产爱克塞尔支架与进口西罗莫可支架疗效比较[J].中国医学创新,2011,8(1):53-54.
-
9高展,乔树宾.经导管心血管治疗学大会:2007回顾[J].中国循环杂志,2008,23(1):76-79.
-
10Lenihan Jr. J.P.,Kovanda C.,Cammarano C.,张剑萍.腹腔镜辅助下经阴道子宫切除术与传统子宫切除术成本效益分析的比较[J].世界核心医学期刊文摘(妇产科学分册),2005,0(1):17-18. 被引量:7